AVTNPL vs NATHBIOGEN: Stock Comparison

AVT Natural Products Limited vs Nath Bio-Genes (India) Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

AVT Natural Products Limited is the larger company by market capitalisation. AVT Natural Products Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Nath Bio-Genes (India) Limited shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of AVT Natural Products Limited and Nath Bio-Genes (India) Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AVTNPL is more favourable on 8 of 13 scored metrics and NATHBIOGEN on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
AVTNPL is the larger company
₹1,062 Cr vs ₹301 Cr
P/E Ratio
NATHBIOGEN has a lower P/E
7.43x vs 16.36x
P/B Ratio
NATHBIOGEN has a lower P/B
0.45x vs 1.9x
EPS
NATHBIOGEN has higher earnings per share
₹20.97 vs ₹4.26
Dividend Yield
AVTNPL has a higher dividend yield
1.3% vs 1.23%
Revenue Growth (TTM YoY)
AVTNPL has faster revenue growth
43.5% vs -1%
EPS Growth (TTM YoY)
AVTNPL has faster EPS growth
54.3% vs 0%
Qtr Sales Growth
AVTNPL has stronger quarterly sales growth
44.4% vs -0.73%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAVTNPLNATHBIOGEN
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryOther Agricultural ProductsOther Agricultural Products

Price

MetricAVTNPLNATHBIOGEN
Live Price₹70.02₹161.13
Day Change-0.07%4.19%
Volume24,47419,108
52-Week High₹83.8₹204
52-Week Low₹53.5₹126.15
Distance from 52W High-16.44%-21.01%

Valuation

MetricAVTNPLNATHBIOGEN
Market Cap₹1,062 Cr₹301 Cr
P/E Ratio16.36x7.43x
P/B Ratio1.9x0.45x
EPS₹4.26₹20.97
Book Value₹36.83₹304.36
Dividend Yield1.3%1.23%

Growth

MetricAVTNPLNATHBIOGEN
Revenue Growth (TTM YoY)43.5%-1%
EPS Growth (TTM YoY)54.3%0%
Qtr Sales Growth44.4%-0.73%
Qtr Profit Growth53.3%-101%

Profitability & Leverage

MetricAVTNPLNATHBIOGEN
ROE12.2%5.47%
ROCE14.2%7.1%
Net Margin9.09%9.35%
Operating Margin12.6%11.8%
Debt to Equity0.2x0.2x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAVTNPLNATHBIOGEN
Promoter Holding75%45.6%
FII Holding0.04% 0.01 pp0.23% 0.08 pp
DII Holding0.02%0.01%
Public Holding24.95%54.17% 0.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AVT Natural Products Limited and Nath Bio-Genes (India) Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.